Members of the SFB/TRR 289 have published a research paper about the Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine. The first authors Dr. Katharina Schmidt and Dr. Julian Kleine-Borgmann belong to the project team of Prof. Ulrike Bingel in Essen.
The publication can be downloaded here or read directly on the BMJ Open site.